Clinical trial NCT00307606 - References

Breast Neoplasms — Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma

Citation(s)

•   Apte RN, Voronov E
  Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol. 2002 Aug;12(4):277-90. Review.
•   Baker EA, Leaper DJ
  Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen. 2000 Sep-Oct;8(5):392-8.
•   Barwell J, Campbell L, Watkins RM, Teasdale C
  How long should suction drains stay in after breast surgery with axillary dissection? Ann R Coll Surg Engl. 1997 Nov;79(6):435-7.
•   Bonnema J, van Geel AN, Ligtenstein DA, Schmitz PI, Wiggers T
  A prospective randomized trial of high versus low vacuum drainage after axillary dissection for breast cancer. Am J Surg. 1997 Feb;173(2):76-9.
•   Browse DJ, Goble D, Jones PA
  Axillary node clearance: who wants to immobilize the shoulder? Eur J Surg Oncol. 1996 Dec;22(6):569-70.
•   Burak WE Jr, Goodman PS, Young DC, Farrar WB
  Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol. 1997 Jan;64(1):27-31.
•   Chilson TR, Chan FD, Lonser RR, Wu TM, Aitken DR
  Seroma prevention after modified radical mastectomy. Am Surg. 1992 Dec;58(12):750-4.
•   Coveney EC, O'Dwyer PJ, Geraghty JG, O'Higgins NJ
  Effect of closing dead space on seroma formation after mastectomy--a prospective randomized clinical trial. Eur J Surg Oncol. 1993 Apr;19(2):143-6.
•   DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B
  Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 2003 Nov 15;63(22):8051-6.
•   Doolin EJ, Tsuno K, Strande LF, Santos MC
  Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Ann Otol Rhinol Laryngol. 1998 Apr;107(4):275-9.
•   Guth AA
  Breast cancer and human immunodeficiency virus infection: issues for the 21st century. J Womens Health (Larchmt). 2003 Apr;12(3):227-32. Review.
•   Harada RN, Pressler VM, McNamara JJ
  Fibrin glue reduces seroma formation in the rat after mastectomy. Surg Gynecol Obstet. 1992 Nov;175(5):450-4.
•   Holcombe C, West N, Mansel RE, Horgan K
  The satisfaction and savings of early discharge with drain in situ following axillary lymphadenectomy in the treatment of breast cancer. Eur J Surg Oncol. 1995 Dec;21(6):604-6.
•   Holte K, Kehlet H
  Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002 Nov;195(5):694-712. Review.
•   Jeffrey SS, Goodson WH 3rd, Ikeda DM, Birdwell RL, Bogetz MS
  Axillary lymphadenectomy for breast cancer without axillary drainage. Arch Surg. 1995 Aug;130(8):909-12; discussion 912-3.
•   Khan AL, Larsen F, Heys SD, Eremin O
  Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol. 1999 Dec;25(6):574-9.
•   Kumar S, Lal B, Misra MC
  Post-mastectomy seroma: a new look into the aetiology of an old problem. J R Coll Surg Edinb. 1995 Oct;40(5):292-4.
•   Liu CD, McFadden DW
  Overnight closed suction drainage after axillary lymphadenectomy for breast cancer. Am Surg. 1997 Oct;63(10):868-70.
•   Medwid A
  A new and quick method for treating postmastectomy seromas. Surg Gynecol Obstet. 1992 Feb;174(2):161-2.
•   Mettler L, Salmassi A, Heyer M, Schmutzier A, Schollmeyer T, Jonat W
  Perioperative levels of interleukin-1beta and interleukin-6 in women with breast cancer. Clin Exp Obstet Gynecol. 2004;31(1):20-2.
•   Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Mizumoto T, Hamamoto R
  An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer. Oncology. 2000 Aug;59(2):166-73.
•   O'Dwyer PJ, O'Higgins NJ, James AG
  Effect of closing dead space on incidence of seroma after mastectomy. Surg Gynecol Obstet. 1991 Jan;172(1):55-6.
•   Oertli D, Laffer U, Haberthuer F, Kreuter U, Harder F
  Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg. 1994 Jun;81(6):856-9.
•   Porter KA, O'Connor S, Rimm E, Lopez M
  Electrocautery as a factor in seroma formation following mastectomy. Am J Surg. 1998 Jul;176(1):8-11.
•   Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA
  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf. 2000 Nov;23(5):449-61.
•   Schultz I, Barholm M, Gröndal S
  Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study. Ann Surg Oncol. 1997 Jun;4(4):293-7.
•   Schulze S, Andersen J, Overgaard H, Nørgard P, Nielsen HJ, Aasen A, Gottrup F, Kehlet H
  Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg. 1997 Feb;132(2):129-35.
•   Stewart T, Tsai SC, Grayson H, Henderson R, Opelz G
  Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet. 1995 Sep 23;346(8978):796-8.
•   Tadych K, Donegan WL
  Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987 Dec;165(6):483-7.
•   Udén P, Aspegren K, Balldin G, Garne JP, Larsson SA
  Fibrin adhesive in radical mastectomy. Eur J Surg. 1993 May;159(5):263-5.
•   Wang JY, Goodman NC, Amiss LR Jr, Nguyen DH, Rodeheaver GT, Moore MM, Morgan RF, Abbott RD, Spotnitz WD
  Seroma prevention in a rat mastectomy model: use of a light-activated fibrin sealant. Ann Plast Surg. 1996 Oct;37(4):400-5.
•   Watt-Boolsen S, Jacobsen K, Blichert-Toft M
  Total mastectomy with special reference to surgical technique, extent of axillary dissection and complications. Acta Oncol. 1988;27(6A):663-5.
•   Watt-Boolsen S, Nielsen VB, Jensen J, Bak S
  Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull. 1989 Oct;36(5):487-9.
•   Yokoe T, Iino Y, Morishita Y
  Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Cancer. 2000;7(3):187-90.

Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma

Details for clinical trial NCT00307606